Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
Authors
Keywords
Cisplatin, Mitogen activated protein kinase, p90 ribosomal s6 kinase, Combination therapy, Synergy, Apoptosis
Journal
Journal of Translational Medicine
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-11
DOI
10.1186/s12967-018-1471-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC).
- (2017) Maeve Aine Lowery et al. JOURNAL OF CLINICAL ONCOLOGY
- Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells
- (2017) Hong Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- LGG-15. CARBOPLATIN IS SYNERGISTIC WITH MAPK INHIBITORS TRAMETINIB AND EVEROLIMUS IN LOW GRADE GLIOMA MODELS
- (2017) Brad Poore et al. NEURO-ONCOLOGY
- Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer
- (2017) Jieun Lee et al. PLoS One
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells
- (2016) Daniela Kramer et al. CELL DEATH AND DIFFERENTIATION
- The p90rsk-mediated signaling of ethanol-induced cell proliferation in HepG2 cell line
- (2016) Han Sang Kim et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines
- (2016) Fabian Arechavaleta-Velasco et al. MEDICAL ONCOLOGY
- Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin
- (2016) Nabeel Abdulrahman et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Potential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and Cisplatin
- (2016) Chia-Yi Tseng et al. PLoS One
- Melatonin potentiates cisplatin-induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells
- (2015) P. Plaimee et al. CELL PROLIFERATION
- Unknown
- (2015) Azhar Hussain et al. MOLECULAR MEDICINE
- Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
- (2015) QU YANG et al. ONCOLOGY REPORTS
- Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines
- (2015) PUTERI BAHARUDDIN et al. ONCOLOGY REPORTS
- Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cells
- (2014) Giacomo Cossa et al. CANCER LETTERS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells
- (2014) Ying-Hsi Lin et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Metformin Enhances Cisplatin Cytotoxicity by Suppressing Signal Transducer and Activator of Transcription–3 Activity Independently of the Liver Kinase B1–AMP-Activated Protein Kinase Pathway
- (2013) Chien-Chung Lin et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma
- (2013) Ahmed O. Kaseb et al. CANCER
- Platinum-Based Agents for Individualized Cancer Treatment
- (2013) X. Chen et al. CURRENT MOLECULAR MEDICINE
- Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK
- (2013) Lorena Pereira et al. EMBO Molecular Medicine
- Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle
- (2013) JAROMIR GUMULEC et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tetraarsenic oxide and cisplatin induce apoptotic synergism in cervical cancer
- (2013) JUNG MI BYUN et al. ONCOLOGY REPORTS
- Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines
- (2013) Panagiotis Apostolou et al. BMC Pharmacology & Toxicology
- The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin
- (2012) Marijn T.M. van Jaarsveld et al. EUROPEAN JOURNAL OF CANCER
- RSK2Ser227 at N-Terminal Kinase Domain Is a Potential Therapeutic Target for Multiple Myeloma
- (2012) Y. Shimura et al. MOLECULAR CANCER THERAPEUTICS
- RSK regulates activated BRAF signalling to mTORC1 and promotes melanoma growth
- (2012) Y Romeo et al. ONCOGENE
- Regulation and function of the RSK family of protein kinases
- (2011) Yves Romeo et al. BIOCHEMICAL JOURNAL
- EGFR-targeted therapies combined with chemotherapy for treating advanced non-small-cell lung cancer: a meta-analysis
- (2011) Peng Chen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells
- (2011) Ji-Hyun Kim et al. JOURNAL OF PINEAL RESEARCH
- Temsirolimus Inhibits Malignant Pleural Mesothelioma Growth In Vitro and In Vivo: Synergism with Chemotherapy
- (2011) Mir Alireza Hoda et al. Journal of Thoracic Oncology
- An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis
- (2011) R Lara et al. ONCOGENE
- Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo
- (2010) Terry OʼReilly et al. ANTI-CANCER DRUGS
- p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells
- (2010) Sumin Kang et al. JOURNAL OF CLINICAL INVESTIGATION
- Shenqi fuzheng, an injection concocted from chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review
- (2010) Ju Dong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma
- (2010) Rong Bu et al. LABORATORY INVESTIGATION
- RSK in tumorigenesis: Connections to steroid signaling
- (2010) T.S. Karin Eisinger-Mathason et al. STEROIDS
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
- (2009) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines
- (2009) Brigette B. Y. Ma et al. INVESTIGATIONAL NEW DRUGS
- Effect of sirolimus on urinary bladder cancer T24 cell line
- (2009) Rosario Pinto-Leite et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer
- (2009) Shahab Uddin et al. LABORATORY INVESTIGATION
- Inhibition of p38-MAPK Potentiates Cisplatin-Induced Apoptosis via GSH Depletion and Increases Intracellular Drug Accumulation in Growth-Arrested Kidney Tubular Epithelial Cells
- (2009) Maria Elena Rodríguez-García et al. TOXICOLOGICAL SCIENCES
- Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies: Figure 1.
- (2008) Jorge A. Garcia et al. MOLECULAR CANCER THERAPEUTICS
- Codependent Functions of RSK2 and the Apoptosis-Promoting Factor TIA-1 in Stress Granule Assembly and Cell Survival
- (2008) T.S. Karin Eisinger-Mathason et al. MOLECULAR CELL
- The RSK family of kinases: emerging roles in cellular signalling
- (2008) Rana Anjum et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma
- (2007) Y. LIU et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started